Elliott Marshall Antman
Brigham and Women's Hospital
3 papers in the Anchorcite directory, published between 2007 and 2018, cited 18,188 times in total.
ORCID profileResearch topics
- Acute Myocardial Infarction Research · 2 papers
- Antiplatelet Therapy and Cardiovascular Diseases · 1 paper
- Coronary Interventions and Diagnostics · 1 paper
- Cardiac Imaging and Diagnostics · 1 paper
- Cardiac Ischemia and Reperfusion · 1 paper
- Acute Ischemic Stroke Management · 1 paper
Frequent co-authors
- Stephen D. Wiviott · 2 papers
- Eugene Braunwald · 2 papers
- Carolyn H. McCabe · 1 paper
- Gilles Montalescot · 1 paper
- Witold Rużyłło · 1 paper
- Shmuel Gottlieb · 1 paper
- F.-J. Neumann · 1 paper
- Diego Ardissino · 1 paper
Papers
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2007 · 6,831 citations
BACKGROUND: Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic complications of acute coronary syndromes and percutaneous coronary intervention. METHODS: To compare prasugrel, a new thienopyridine, with clopidogrel, we randomly assigned 13,608 patients with…
- Fourth universal definition of myocardial infarction (2018)European Heart Journal · 2018 · 6,098 citations
... ... ... ... In the late 19th century, post-mortem examinations demonstrated a possible relationship between thrombotic occlusion of a coronary artery and myocardial infarction (MI).1 However, it was not until the beginning of the 20th century that the first…
- Edoxaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2013 · 5,259 citations
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial…
Metadata from OpenAlex (CC0).